Zivo Bioscience, Inc. ZIVO

ZIVO Company Overview

Zivo Bioscience, Inc. is a biotechnology company focused on the development of novel biologic and immune‑modulating therapeutics derived from proprietary algal technology. The company operates primarily in the biotechnology and life sciences industries, with research emphasis on immunology, infectious disease, and inflammatory conditions. Its core business model centers on discovering, developing, and commercializing therapeutic candidates that leverage naturally derived compounds with potential broad immune‑supporting applications.

The company’s primary value driver is its proprietary platform based on algal biomass–derived bioactive compounds, which are designed to modulate immune responses rather than target single disease pathways. Zivo Bioscience traces its origins to earlier algal research initiatives and has evolved into a public biotechnology company through corporate restructuring and strategic refocusing on human and animal health applications. Its strategy emphasizes preclinical and early‑stage clinical development, with a long‑term objective of partnering or licensing successful candidates to larger pharmaceutical or animal health companies.